Procter & Gamble Hygiene and Health Care Limited

NSE: PGHH · Unclassified

₹6,982.00-0.66%06 Nov 2026

Ask the data

Instant answers about Procter & Gamble Hygiene and Health Care Limited — computed from its filings, no language model

Market cap₹22,664 cr

Current price₹6,982.00

High / Low₹13,413 / ₹6,639

P/E28.7

P/B30.08

Book value₹232.1

ROE104.9%

ROCE143.5%

Debt / equity0.00

Dividend yield3.72%

EPS (TTM)₹243.60

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 17 periods

	Jun '08†	Jun '09†	Jun '10†	Jun '11†	Jun '12†	Jun '13†	Jun '14†	Jun '15†	Jun '16†	Jun '17†	Jun '18	Jun '20	Jun '21	Jun '22	Jun '23	Jun '24	FY26
Revenue	644	774	904	1,007	1,297	1,687	2,051	2,334	2,484	2,419	2,455	3,002	3,574	3,901	3,918	4,206	4,290
EBITDA	177	209	230	163	197	247	421	484	605	665	615	604	884	830	869	970	1,171
Operating margin	27.5%	27.0%	25.4%	16.1%	15.2%	14.6%	20.5%	20.8%	24.3%	27.5%	25.1%	20.1%	24.7%	21.3%	22.2%	23.1%	27.3%
Interest	—	—	—	—	—	—	—	6	4	10	5	6	6	11	11	27	9
Depreciation	12	14	25	22	28	31	35	53	52	60	52	48	48	53	58	56	37
Profit before tax	181	232	234	177	223	286	460	501	637	672	582	594	870	790	839	939	1,167
Tax	49	53	54	26	42	83	158	155	213	239	207	161	218	214	161	264	310
Net profit	131	179	180	151	181	203	302	346	423	433	0	433	652	576	678	675	856
EPS ₹	—	—	—	—	—	—	—	—	—	—	115.40	133.42	200.79	177.37	208.91	207.95	263.86
Operating cash flow	—	—	—	—	—	—	—	—	—	—	—	—	863	573	826	471	924
Capex	—	—	—	—	—	—	—	—	—	—	—	—	32	50	44	45	0
Dividend paid	—	—	—	—	—	—	—	—	—	—	—	—	1,104	568	471	860	844
Total assets	—	—	—	—	—	—	—	—	—	—	—	—	—	1,681	2,137	1,859	1,804
Equity	—	—	—	—	—	—	—	—	—	—	—	—	—	738	946	775	753

Quarterly performance

last 75 quarters · ₹ crore

showing latest 8 of 75 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25*	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Revenue	151	194	149	151	189	226	178	181	226	275	205	198	228	299	235	245	302	355	327	313	376	471	417	423	493	571	501	486	576	645	555	558	599	714	614	558	622	666	601	530	658	704	569	525	792	818	699	852	859	656	635	1,009	1,018	760	787	1,058	1,093	973	776	1,045	1,137	883	853	1,138	1,133	1,002	932	1,135	1,248	-256	937	1,150	1,262	941	891
Operating profit	48	64	40	25	58	54	32	65	70	97	44	20	36	56	46	24	35	61	57	44	43	66	65	73	73	96	109	142	79	128	123	154	97	216	133	159	151	229	154	131	187	210	134	84	210	191	144	182	187	125	110	338	342	136	75	301	296	165	67	214	290	149	215	285	310	257	118	290	371	-161	266	285	402	218	170
Operating margin	31.6%	33.1%	27.0%	16.5%	30.7%	23.8%	17.8%	35.9%	30.8%	35.3%	21.3%	9.9%	15.8%	18.7%	19.7%	9.9%	11.6%	17.3%	17.5%	13.9%	11.4%	14.0%	15.7%	17.2%	14.9%	16.8%	21.7%	29.2%	13.7%	19.9%	22.1%	27.7%	16.2%	30.3%	21.7%	28.4%	24.3%	34.3%	25.6%	24.7%	28.5%	29.9%	23.5%	16.0%	26.5%	23.4%	20.5%	21.4%	21.7%	19.0%	17.4%	33.5%	33.6%	17.9%	9.5%	28.5%	27.1%	17.0%	8.6%	20.5%	25.5%	16.9%	25.2%	25.0%	27.3%	25.7%	12.7%	25.6%	29.7%	63.0%	28.4%	24.8%	31.8%	23.2%	19.1%
Other income	4	4	3	4	6	7	18	6	5	6	17	1	9	8	8	11	13	13	18	11	28	14	15	13	22	22	16	20	21	17	18	19	21	21	24	22	23	21	23	11	4	7	7	7	24	12	8	11	9	15	10	10	9	15	6	6	7	6	6	7	9	14	10	16	16	14	7	8	10	9	8	10	12	12	9
Interest	—	—	0	—	—	—	—	—	—	0	0	—	—	0	—	0	—	—	0	0	—	—	—	0	0	—	0	5	1	0	4	0	1	2	0	0	0	4	1	4	0	0	0	4	0	0	1	0	2	2	1	0	2	3	1	1	3	7	1	1	4	4	3	2	3	22	-0	2	7	-1	0	4	3	3	0
Depreciation	3	3	4	3	3	3	4	4	6	5	4	10	5	5	6	6	6	7	7	8	8	7	8	9	8	9	9	9	11	16	12	13	13	14	12	12	13	13	14	20	13	14	14	12	12	12	13	11	11	12	13	12	12	19	13	13	13	13	14	14	14	15	15	14	14	15	13	12	10	0	9	9	10	10	10
Profit before tax	50	65	40	26	61	58	46	67	69	98	56	11	40	58	49	29	41	67	68	46	63	73	73	77	87	110	116	148	88	129	125	160	104	220	144	168	161	232	161	118	178	203	126	74	221	190	139	181	182	125	106	336	338	129	67	294	288	151	58	206	282	146	207	284	309	234	112	285	364	-151	265	282	402	218	170
Tax	15	19	12	3	12	11	11	19	17	23	12	1	9	13	10	-6	-1	16	16	11	18	19	21	25	32	33	35	58	26	38	38	52	34	73	47	59	56	81	62	40	62	72	43	30	77	66	49	45	46	34	36	82	87	31	18	76	75	48	15	51	74	-19	55	74	80	80	31	73	96	-39	73	72	101	65	43
Net profit	34	46	27	23	49	47	35	48	51	75	44	10	31	45	39	36	43	51	52	35	45	54	52	52	55	77	81	90	62	91	87	107	70	147	97	109	104	151	100	78	116	131	0	0	144	124	90	137	136	91	69	254	251	98	49	218	212	103	43	154	207	165	151	211	229	154	81	212	269	-112	192	210	301	153	126
EPS ₹	10.60	14.30	8.40	7.20	15.10	14.50	10.73	14.72	15.86	23.00	13.50	3.11	9.66	13.85	11.99	10.98	13.18	15.77	16.04	10.87	13.95	16.63	16.05	15.98	16.88	23.59	24.88	27.70	18.95	27.93	26.77	32.99	21.50	45.19	29.98	33.70	32.17	46.40	30.69	24.04	35.60	40.43	25.64	13.72	44.40	38.24	27.76	42.16	41.88	28.07	21.32	78.21	77.21	30.29	15.09	67.25	65.33	31.68	13.11	47.57	63.91	50.84	46.59	64.91	70.51	47.56	24.97	65.28	82.74	-34.65	59.17	64.65	92.87	47.17	38.90
Revenue YoY	—	—	—	—	24.8%	16.8%	19.5%	20.3%	19.6%	21.7%	15.5%	9.2%	1.1%	8.7%	14.3%	23.6%	32.4%	18.7%	39.2%	27.8%	24.4%	32.7%	27.7%	35.1%	31.2%	21.3%	20.0%	14.9%	17.0%	12.8%	10.9%	14.7%	3.8%	10.7%	10.5%	0.1%	4.0%	-6.7%	-2.1%	-5.1%	5.6%	5.8%	-5.4%	-1.0%	20.4%	16.2%	22.9%	7.6%	5.0%	-6.2%	—	18.5%	18.5%	15.8%	24.0%	4.8%	7.3%	28.1%	-1.3%	-1.3%	4.1%	-9.3%	9.8%	8.9%	-0.3%	13.5%	9.3%	-0.3%	10.1%	-125.5%	0.6%	1.3%	1.1%	—	-4.9%
Profit YoY	—	—	—	—	42.5%	1.7%	27.3%	105.6%	4.7%	58.2%	25.4%	-78.9%	-39.1%	-39.7%	-10.8%	252.8%	36.4%	13.9%	33.7%	-1.0%	5.8%	5.5%	0.1%	47.1%	21.0%	41.8%	55.0%	73.4%	12.2%	18.4%	7.6%	19.1%	13.5%	61.8%	12.0%	2.2%	49.7%	2.7%	2.4%	-28.7%	10.6%	-12.9%	-100.0%	-100.0%	24.7%	-5.4%	—	-5.0%	9.5%	1.1%	—	85.5%	84.4%	7.9%	-29.2%	-14.0%	-15.4%	4.6%	-13.1%	-29.3%	-2.2%	60.4%	255.4%	36.4%	10.3%	-6.5%	-46.4%	0.6%	17.3%	-172.9%	136.9%	-1.0%	12.2%	—	-34.3%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 69 periods

	JUN '08	SEP '08	DEC '08	MAR '09	JUN '09	SEP '09	DEC '09	MAR '10	JUN '10	SEP '10	DEC '10	MAR '11	JUN '11	SEP '11	DEC '11	MAR '12	JUN '12	SEP '12	DEC '12	MAR '13	JUN '13	SEP '13	DEC '13	MAR '14	JUN '14	SEP '14	DEC '14	MAR '15	JUN '15	SEP '15	DEC '15	MAR '16	JUN '16	SEP '16	DEC '16	MAR '17	JUN '17	SEP '17	DEC '17	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
ROE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	78.1%	69.4%	68.8%	77.2%	71.7%	77.6%	71.8%	70.8%	87.1%	87.3%	75.7%	60.9%	76.0%	59.9%	63.4%	113.7%	104.9%
ROCE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	108.6%	96.8%	96.1%	94.9%	89.9%	98.4%	90.8%	101.0%	124.7%	124.8%	108.6%	83.8%	104.5%	82.5%	86.2%	156.1%	143.5%
Net margin	20.4%	21.4%	20.6%	20.8%	23.1%	22.3%	24.3%	24.5%	19.9%	17.6%	14.0%	13.1%	15.0%	15.0%	14.8%	14.8%	14.0%	13.4%	12.6%	11.8%	12.0%	11.8%	12.4%	13.3%	14.7%	14.5%	14.6%	14.5%	14.8%	15.0%	16.9%	16.9%	17.0%	18.3%	18.8%	19.0%	17.9%	18.1%	17.0%	13.2%	10.1%	10.6%	9.9%	12.6%	14.4%	17.4%	20.0%	19.6%	18.2%	17.0%	15.6%	14.9%	14.8%	13.2%	12.9%	14.8%	17.3%	18.3%	18.9%	18.1%	16.1%	16.1%	16.6%	14.7%	18.3%	18.1%	19.1%	20.0%	18.6%
EBITDA margin	27.5%	27.5%	24.8%	22.7%	27.0%	27.2%	30.6%	31.0%	25.4%	21.7%	16.7%	16.5%	16.1%	14.9%	14.7%	14.4%	15.2%	14.9%	14.1%	13.8%	14.6%	15.4%	16.2%	17.7%	20.5%	20.0%	20.8%	20.9%	20.8%	21.3%	24.3%	24.2%	24.3%	26.3%	27.3%	28.3%	27.5%	28.6%	27.4%	26.9%	25.1%	24.6%	22.9%	22.2%	20.1%	24.1%	27.6%	27.1%	25.0%	23.6%	21.9%	21.4%	21.3%	19.1%	18.7%	18.8%	22.2%	23.4%	23.9%	25.9%	23.1%	23.2%	24.0%	20.2%	25.0%	24.7%	25.6%	27.3%	25.3%
Debt / equity	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest coverage	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	69.72	47.29	88.55	91.58	81.58	158.41	159.34	210.98	135.24	114.86	65.47	67.25	100.75	111.08	110.36	118.20	115.49	114.67	98.84	124.26	154.20	142.47	143.37	131.60	108.88	73.17	71.61	61.79	56.82	75.90	74.77	75.52	86.84	35.61	36.07	36.08	33.26	81.30	99.42	81.42	146.18	124.45	112.04
Asset turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.32	2.31	2.34	2.29	1.83	1.88	1.80	1.85	2.26	2.26	2.06	1.74	1.75	1.44	1.45	2.38	2.35

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	JUN '22	JUN '23	DEC '23	JUN '24	DEC '24	MAR '25	SEP '25	MAR '26
Share capital	32	32	32	32	32	32	32	32
Other equity / reserves	705	914	1,020	742	913	705	899	721
Total equity	738	946	1,052	775	946	737	931	753
Borrowings	0	0	0	0	0	0	0	0
Current liabilities	858	1,085	1,065	981	1,041	901	1,086	935
Non-current liabilities	86	106	109	103	110	117	116	115
Total assets	1,681	2,137	2,227	1,859	2,097	1,755	2,133	1,804
Property, plant & equipment	164	170	160	139	145	131	166	163
Capital work-in-progress	44	23	20	28	33	41	14	21
Investments	0	0	0	0	0	0	0	0
Inventories	234	220	185	226	241	221	216	218
Receivables	191	216	297	241	310	304	358	243
Cash & equivalents	625	964	688	574	774	466	782	557

Cash flow

annual · ₹ crore · line = free cash flow

	Jun '21	Jun '22	Jun '23	Jun '24	FY26
Cash from operations	863	573	826	471	924
Cash from investing	7	-27	-10	1	11
Cash from financing	-1,106	-569	-477	-862	-845
Capex	32	50	44	45	0
Free cash flow	832	523	781	426	924
Dividends paid	1,104	568	471	860	844

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹163 cr9%

CWIP

₹21 cr1%

Inventories

₹218 cr12%

Receivables

₹243 cr13%

Cash & equivalents

₹557 cr31%

Other assets

₹601 cr33%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Procter & Gamble Hygiene and Health Care Limited	22,664	6,982.00	28.7	30.08	104.9%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+0.9%

6 months-29.4%

1 year-48.1%

3Y CAGR-26.6%

5Y CAGR-13.5%

10Y CAGR+0.1%

50-day avg₹7,227.27

200-day avg₹9,233.25

RSI (14)42

FAQs

What is the share price of Procter & Gamble Hygiene and Health Care Limited?

Procter & Gamble Hygiene and Health Care Limited (PGHH) closed at ₹6,982.00 on NSE on 06 Nov 2026.

What is the market cap of Procter & Gamble Hygiene and Health Care Limited?

₹22,664 crore at the latest close.

What is the P/E ratio of Procter & Gamble Hygiene and Health Care Limited?

28.7, on trailing-twelve-month earnings from its filings.

How fast is Procter & Gamble Hygiene and Health Care Limited growing?

Procter & Gamble Hygiene and Health Care Limited: revenue has compounded at 3.2% a year over three years; net profit at 14.2% a year. Latest-quarter revenue is down 4.9% year on year, profit down 34.3%.

How profitable is Procter & Gamble Hygiene and Health Care Limited?

On a trailing-twelve-month basis return on equity is 104.9%, return on capital employed 143.5%, operating margin 25.3%, net margin 18.6%.

How much debt does Procter & Gamble Hygiene and Health Care Limited have?

Procter & Gamble Hygiene and Health Care Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹557 cr (balance sheet of 2026-03-31). Operating profit covers interest 112.0 times.

Financials parsed from Procter & Gamble Hygiene and Health Care Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from SEP '07, annual from Jun '08, balance sheet from Jun '22. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before MAR '18 (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.